While our approach was not designed to cure DMD by attempting to re-express dystrophin per se, we hypothesized that the treatment with growth factors would improve muscle function and that peri-onset treatment would improve muscle function more than post-onset treatment and delay or attenuate the compensatory hypertrophy, affecting specific force generation positively. The gene discussed is DMD; the disease is Duchenne muscular dystrophy.